32 Biosciences
32 Biosciences (pronounced "Three Squared") is a North Chicago, Illinois gastrointestinal biotechnology company founded in 2023 that pioneers gut mucosal-immune science to prevent and treat GI disease. It emerged from stealth in September 2024 and is built on research by scientific co-founders John Alverdy MD and Eugene Chang MD of the University of Chicago and Joseph Pierre PhD of the University of Wisconsin-Madison, with Peter Farmakis as CEO. The company runs two platforms - a GI Discovery Platform that measures metabolomic signatures of gut mucosal-immune function for therapeutic discovery and clinical decision-making, and a CS Therapeutic Platform whose lead asset CS-0003 is a Mucosal Immune Modulator intended to restore and protect the GI mucosal-immune barrier across seven indications. It raised $6 million in early funding and announced a $40 million Series A launch at the 2026 J.P. Morgan Healthcare Conference. 32 Biosciences publishes no product or developer API and runs no developer program; the only machine-readable surface on 32biosciences.com is the WordPress REST API (wp/v2) that serves the company newsroom, marketing and platform pages, leadership profiles, taxonomies and media library as JSON, alongside a WordPress Abilities registry that is present but authentication-gated.
32 Biosciences publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Gastroenterology, and Microbiome.
32 Biosciences’ developer surface includes authentication, product news, engineering blog, support, code examples, and 24 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
32 Biosciences Website (WordPress REST)
The public WordPress REST API (wp-json) of the 32 Biosciences website at 32biosciences.com: the route index of the site's content management system, catalogued as one site surfa...
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
32 Biosciences Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 2
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 6
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.